Short communication: Evidence of HIV type 1 clade C env clones containing low V3 loop charge obtained from an AIDS patient in India that uses CXCR6 and CCR8 for entry in addition to CCR5

AIDS Research and Human Retroviruses

Volumn 27, Issue 2, 2011, Pages 211-219

  Gharu, Lavina ^a   Ringe, Rajesh ^a   Satyakumar, Anupindi ^a   Patil, Ajit ^a   Bhattacharya, Jayanta ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR6;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE REPORT; CLADISTICS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INDIA; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS STRAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, ENV; HIV-1; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR5; RECEPTORS, CCR8; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS;

EID: 79951698772     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0180     Document Type: Article

References (48)

1. Shimizu N, Tanaka A, Mori T, Ohtsuki T, Hoque A, Jinno- Oue A, et al.: A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus. Retrovirology 2008;5:52.
2. Berger EA: HIV entry and tropism. When one receptor is not enough. Adv Exp Med Biol 1998;452:151-157. (Pubitemid 28478093)
3. Berger EA, Murphy PM, and Farber JM: Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700. (Pubitemid 29241137)
4. Coetzer M, Nedellec R, Salkowitz J, McLaughlin S, Liu Y, Heath L, et al.: Evolution of CCR5 use before and during coreceptor switching. J Virol 2008;82:11758-11766.
5. Shimizu N, Tanaka A, Oue A, Mori T, Ohtsuki T, Apichartpiyakul C, et al.: Broad usage spectrum of G proteincoupled receptors as coreceptors by primary isolates of HIV. AIDS 2009;27:761-769.
6. Nedellec R, Coetzer M, Shimizu N, Hoshino H, Polonis VR, Morris L, et al.: Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J Virol 2009;83:8353-8363.
7. Clapham PR and McKnight A: HIV-1 receptors and cell tropism. Br Med Bull 2001;58:43-59. (Pubitemid 33070763)
8. Clapham PR and McKnight A: Cell surface receptors, virus entry and tropism of primate lentiviruses. J Gen Virol 2002; 83:1809-1829. (Pubitemid 34846445)
9. Clapham PR, Reeves JD, Simmons G, Dejucq N, Hibbitts S, and McKnight A: HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands. Mol Membr Biol 1999; 16:49-55. (Pubitemid 29179337)
10. Berger EA, Doms RW, Fenyo EM, Korber BT, Littman DR, Moore JP, et al.: A new classification for HIV-1. Nature 1998; 391:240.
11. Cho MW, Lee MK, Carney MC, Berson JF, Doms RW, and Martin MA: Identification of determinants on a dual tropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J Virol 1998; 72:2509-2515. (Pubitemid 28100815)
12. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, and Lusso P: The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 1996;2:1244-1247. (Pubitemid 26375410)
13. Hwang SS, Boyle TJ, Lyerly HK, and Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253:71-74. (Pubitemid 21917121)
14. Wang ZX, Berson JF, Zhang TY, Cen YH, Sun Y, Sharron M, et al.: CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins. J Biol Chem 1998;273:15007-15015. (Pubitemid 28272794)
15. Yu XF, Wang Z, Vlahov D, Markham RB, Farzadegan H, and Margolick JB: Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. J Infect Dis 1998;178:388-396. (Pubitemid 28347920)
16. Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, and Gadkari DA: Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000;271:253-258. (Pubitemid 30461303)
17. Schuitemaker H, Kootstra NA, de Goede RE, de Wolf F, Miedema F, and Tersmette M: Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991;65:356-363.
18. Valentin A, Albert J, Fenyo EM, and Asjo B: Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J Virol 1994;68:6684-6689.
19. Locati M and Murphy PM: Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS. Annu Rev Med 1999;50:425-440. (Pubitemid 29117076)
20. Glushakova S, Yi Y, Grivel JC, Singh A, Schols D, De Clercq E, et al.: Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J Clin Invest 1999;104:R7-R11.
21. Li S, Juarez J, Alali M, Dwyer D, Collman R, Cunningham A, and Naif HM: Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J Virol 1999;73:9741-9755.
22. Regoes RR and Bonhoeffer S: The HIV coreceptor switch: A population dynamical perspective. Trends Microbiol 2005; 13:269-277. (Pubitemid 40779815)
23. Schuitemaker H and Kootstra NA: Determination of co-receptor usage of HIV-1. Methods Mol Biol 2005;304:327-332.
24. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992;66:1354-1360.
25. Weber J: The pathogenesis of HIV-1 infection. Br Med Bull 2001;58:61-72. (Pubitemid 33070764)
26. Coetzer M, Cilliers T, Papathanasopoulos M, Ramjee G, Karim SA, Williamson C, and Morris L: Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. AIDS Res Hum Retroviruses 2007;23:316-321. (Pubitemid 46418346)
27. Lahuerta M, Aparicio E, Bardaji A, Marco S, Sacarlal J, Mandomando I, et al.: Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique. AIDS Res Hum Retroviruses 2008;24:327-335. (Pubitemid 351282098)
28. Morris L, Cilliers T, Bredell H, Phoswa M, and Martin DJ: CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res Hum Retroviruses 2001;17:697-701. (Pubitemid 32692408)
29. Peeters M, Vincent R, Perret JL, Lasky M, Patrel D, Liegeois F, et al.: Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:115-121. (Pubitemid 29063708)
30. Gharu L, Ringe R, Pandey S, Paranjape R, and Bhattacharya J: HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop. Virus Res 2009;144:306-314.
31. Johnston ER, Zijenah LS, Mutetwa S, Kantor R, Kittinunvorakoon C, and Katzenstein DA: High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J Virol 2003;77: 7682-7688. (Pubitemid 36734540)
32. Cilliers T, Nhlapo J, Coetzer M, Orlovic D, Ketas T, Olson WC, et al.: The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J Virol 2003;77:4449-4456. (Pubitemid 36350986)
33. Isaacman-Beck J, Yi Y, Ratcliffe SJ, Mulenga J, Allen S, Hunter E, Derdeyn CA, and Collman RG: Heterosexual transmission of human immunodeficiency virus Type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J Virol 2009;83:8208-8220.
34. Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, et al.: Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005;79:10108-10125. (Pubitemid 41098552)
35. Peters PJ, Bhattacharya J, Hibbitts S, Dittmar MT, Simmons G, Bell J, et al.: Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol 2004;78: 6915-6926. (Pubitemid 38781530)
36. Lakhashe S, Tripathy S, Paranjape R, and Bhattacharya J: Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. AIDS Res Hum Retroviruses 2008;24:92-99.
37. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, et al.: Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002;46:1896-1905. (Pubitemid 34535213)
38. Willey SJ, Reeves JD, Hudson R, Miyake K, Dejucq N, Schols D, et al.: Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells. J Virol 2003;77:6138-6152. (Pubitemid 36588385)
39. Horuk R, Hesselgesser J, Zhou Y, Faulds D, Halks-Miller M, Harvey S, et al.: The CC chemokine I-309 inhibits CCR8- dependent infection by diverse HIV-1 strains. J Biol Chem 1998;273:386-391. (Pubitemid 28042222)
40. Ogert RA, Lee MK, Ross W, Buckler-White A, Martin MA, and Cho MW: N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dual tropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J Virol 2001;75:5998-6006. (Pubitemid 32553130)
41. Pollakis G, Abebe A, Kliphuis A, Chalaby MI, Bakker M, Mengistu Y, et al.: Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. J Virol 2004;78:2841-2852. (Pubitemid 38314342)
42. Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, and Paxton WA: N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001;276:13433-13441.
43. Blay WM, Gnanakaran S, Foley B, Doria-Rose NA, Korber BT, and Haigwood NL: Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques. J Virol 2006; 80:999-1014. (Pubitemid 43062911)
44. Chohan B, Lang D, Sagar M, Korber B, Lavreys L, Richardson B, and Overbaugh J: Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 2005;79:6528-6531. (Pubitemid 40617257)
45. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, et al.: Envelope-constrained neutralization- sensitive HIV-1 after heterosexual transmission. Science 2004;303:2019-2022. (Pubitemid 38393277)
46. Dejucq N, Simmons G, and Clapham PR: Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5. J Virol 1999;73:7842-7847. (Pubitemid 29383271)
47. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, and Chen IS: Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987; 236:819-822. (Pubitemid 17071156)
48. Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, Weber J, et al.: Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-8360. (Pubitemid 26378410)